Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Flex Ltd (FLEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Flex Ltd — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Flex Ltd trades at $116.02 (market cap $44.09B). The key difference: Flex Ltd is far larger — about 9.4× Definium Therapeutics Inc. Common Shares's market cap, and Flex Ltd is more actively traded (3,022,166 versus 1,966,636). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Flex Ltd for 3 Days on average.
| DFTX | FLEX | |
|---|---|---|
Market Cap | $4.71B | $44.09B |
Volume | 1,966,636 | 3,022,166 |
Sector | Health | Technology |
52-Week High | $48.45 | $162.07 |
52-Week Low | $10.68 | $54.51 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $3.67B | $47.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Flex Ltd
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →
